Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Nature Cancer|January 8, 2026
Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunityPilar M Moreno-Sanchez, Mahsa Rezaeipour, Else Marit Inderberg, et al.Oncoimmunology|August 31, 2012
Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001Else-Marit Inderberg-Suso, Sissel Trachsel, Kari Lislerud, et al.Methods in Cell Biology|March 28, 2024
In vitro re-challenge of CAR T cellsClara Helena Klee, Alicia Villatoro, Nicholas Paul Casey, et al.Antibody Therapeutics|April 30, 2021
Chimeric antigen receptor preparation from hybridoma to T-cell expressionHakan Köksal, Elizabeth Baken, David John Warren, et al.Journal of Personalized Medicine|July 2, 2021
Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate CancerIngrid Jenny Guldvik, Lina Ekseth, Amar U Kishan, et al.Case Reports in Immunology|March 12, 2020
Posttransplantation Lymphoproliferative Disease Treated by RetransplantationIngerid Weum Abrahamsen, Bjørn Christer Grønvold, Else Marit Inderberg, et al.STAR Protocols|December 31, 2024
Protocol for production of tonic CAR T cells with dasatinibLéa Rosselle, Thibault Leray, Sandy Joaquina, et al.Oncoimmunology|July 8, 2021
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumorsPierre Dillard, Nicholas Casey, Sylvie Pollmann, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 23, 2021
"Built-in" PD-1 blocker to rescue NK-92 activity from PD-L1-mediated tumor escape mechanismsNadia Mensali, Pierre Dillard, Artem Fayzullin, et al.Cancer Immunology, Immunotherapy : CII|June 20, 2019
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapyNadia Mensali, Marit Renée Myhre, Pierre Dillard, et al.Pageof 6